CD274 and cancer: Collectively, these results indicate that CDNVs engineered to express PD1 could modulate biological interactions between PD1 and PD-L1, thereby enhancing anti-tumor T cell responses as well as stimulating innate anti-tumor immunity by improving the ability of NK cells to detect and destroy cancer cells.